{name}
{subtitle}
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
city
~15 mi. (Lexington, Massachusetts, +89 more cities)
facility
Massachusetts General Hospital; Lurie Center for Autism
biomarker
ER Positive, +1 more biomarker
drug
giredestrant, +1 more drug
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~19 mi. (Burlington, Massachusetts, +144 more cities)
facility
Lahey Hospital & Medical Center ( Site 0090)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
city
~19 mi. (Newton, Massachusetts, +207 more cities)
facility
MGH Newton-Wellesley Hospital's Vernon Cancer Center ( Site 0082)
biomarker
ER Positive, +1 more biomarker
drug
cyclophosphamide, +6 more drugs
drug type
chemotherapy, +3 more types
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~19 mi. (Burlington, Massachusetts, +825 more cities)
facility
Lahey Hospital and Medical Center
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
city
~19 mi. (Burlington, Massachusetts, +240 more cities)
facility
Lahey Hospital and Medical Center
condition
Endometrial Adenocarcinoma, +5 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type